Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy

Clinical and Applied Thrombosis/Hemostasis

Volumn 13, Issue 2, 2007, Pages 161-165

  Stine, Kimo C ^a   Saylors, Robert L ^a   Suzanne Saccente, C ^a   Becton, David L ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

DVT; Enoxaparin; Pediatric malignancy

Indexed keywords

ASPARAGINASE; ASPARAGINASE MACROGOL; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ENOXAPARIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; B CELL LEUKEMIA; BLEEDING; BLOOD CLOT; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CAVA VEIN; CEREBROVASCULAR ACCIDENT; CHILDHOOD CANCER; CLINICAL ARTICLE; DATA ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FEMORAL VEIN; HODGKIN DISEASE; HUMAN; HYPERCOAGULABILITY; ILIAC VEIN; LARGE CELL LYMPHOMA; LOW DRUG DOSE; LUNG EMBOLISM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SCHOOL CHILD; T CELL LEUKEMIA; THROMBOSIS; TREATMENT DURATION;

ADOLESCENT; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; ENOXAPARIN; FEMALE; HUMANS; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 34047251655     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029606298989     Document Type: Article

References (18)

1. David M., Andrew M. Venous thromboembolic complications in children. J Pediatr 1993 ; 123 (3). 337.
2. Mitchell L., Andrew M., Hanna K., et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003 ; 97 (2). 508.
3. Monagle P., Michelson A., Bovill E., Andrew M. Antithrombotic therapy in children. Chest 2001 ; 119: 344s.
4. Hutten B., Prins M., Gent M., et al. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A restrospective analysis. J Clin Oncol 2000 ; 18 (17). 3078.
5. Glaser D., Medeiros D., Rollins N., Buchanan G. Catheter-related thrombosis in children with cancer. J Pediatr 2001 ; 138 (2). 255.
6. Klerk C., Smorenburg S., Buller H. Thrombosis prophylaxis in patient populations with a central venous catheter: A systematic review. Arch Intern Med 2003 ; 163 (16). 1913.
7. Goldberg R., Seneff M., Gore J., et al. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med 1987 ; 147 (2). 251.
8. Sutor AH, Chan Akc, Massicotte P. Low-molecular-weight heparin in pediatric patients. Semin Thromb Hemost 2004 ; 30 (Supplement 1). 31.
9. Weitz JI Low-molecular-weight heparins. N Engl J Med 1997 ; 337: 688.
10. Levine M. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb Haemost 1997 ; 78 (1). 133.
11. Falanga A. Mechanisms of hypercoagulation in malignancy and during chemotherapy. Haemostasis 1998 ; 28 (Suppl 3). 50.
12. Meyer G., Marjanovic Z., Valcke J., et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study. Arch Intern Med 2002 ; 162 (15). 1729.
13. Prandoni P., Lensing A., Piccioli A., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002 ; 100 (10). 3484.
14. Andrew M., David M., Adams M., et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood 1994 ; 83 (5). 1251.
15. Nowak-Gottl U., von Kries R., Gobel U. Neonatal symptomatic thromboembolism in Germany: Two year survey. Arch Dis Child Fetal Neonatal Ed 1997 ; 76 (3). F163.
16. van Ommen C., Heijboer H., Buller H., et al. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001 ; 139 (5). 676.
17. Hull R., Raskob G., Hirsh J., Sackett D. A cost-effectiveness analysis of alternative approaches for long-term treatment of proximal venous thrombosis. JAMA 1984 ; 252 (2). 235.
18. Levine M. Managing thromboembolic disease in the cancer patient; efficacy and safety of antithrombotic treatment options in patients with cancer. Cancer Treat Rev 2002 ; 28 (3). 145.